Share chart Eliem Therapeutics, Inc.
Extended chart
Simple chart
About Eliem Therapeutics, Inc.
Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its lead drug candidate is ETX-123, a Kv7.2/3 potassium channel opener, which is in preclinical for the treatment of neuronal excitability disorders, such as epilepsy, pain, depression, and others; and ETX-155 for the treatment of major depressive disorder and focal onset seizures that is in Phase 2a clinical trial. more details| IPO date | 2021-08-10 |
|---|---|
| ISIN | US28658R1068 |
| Industry | Biotechnology |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Сайт | https://eliemtx.com |
| Цена ао | 3.09 |
| Change price per day: | 0% (3.09) |
|---|---|
| Change price per week: | 0% (3.09) |
| Change price per month: | 0% (3.09) |
| Change price per 3 month: | 0% (3.09) |
| Change price per half year: | -39.41% (5.1) |
| Change price per year: | -34.95% (4.75) |
| Change price per 3 year: | -62.99% (8.35) |
| Change price per year to date: | 0% (3.09) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| RA Capital Management, L.P. | 13150849 | 47.44 |
| Bml Capital Management, LLC | 2180000 | 7.86 |
| Driehaus Capital Management, LLC | 811680 | 2.93 |
| Vanguard Group Inc | 310486 | 1.12 |
| Atom Investors LP | 78276 | 0.28 |
| Geode Capital Management, LLC | 66626 | 0.24 |
| Bridgeway Capital Management, Inc. | 55223 | 0.2 |
| Northern Trust Corporation | 48712 | 0.18 |
| Blackrock Inc. | 31145 | 0.11 |
| Tudor Investment Corporation | 29490 | 0.11 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Ms. Emily Pimblett | Chief Accounting Officer | N/A | 1984 (41 year) |
| Ms. Jo Palmer-Phillips Ph.D. | Chief Development Officer | N/A | |
| Dr. Aoife M. Brennan BAO, BCh, M.D., MB, MMSc | CEO, President & Director | 1976 (49 years) | |
| Dr. Brett Kaplan M.B.A., M.D. | COO & Principal Financial Officer | 1974 (51 year) | |
| Dr. Nishi Rampal M.D. | Senior Vice President of Clinical Development |
Address: United States, Redmond. WA, 23515 NE Novelty Hill Road - open in Google maps, open in Yandex maps
Website: https://eliemtx.com
Website: https://eliemtx.com
